首页   按字顺浏览 期刊浏览 卷期浏览 Chimiotherapie Des Leucemies Chroniques
Chimiotherapie Des Leucemies Chroniques

 

作者: RamioulH.,  

 

期刊: Acta Clinica Belgica  (Taylor Available online 1962)
卷期: Volume 17, issue 1  

页码: 45-54

 

ISSN:1784-3286

 

年代: 1962

 

DOI:10.1080/17843286.1962.11717687

 

出版商: Taylor&Francis

 

数据来源: Taylor

 

摘要:

SummaryThe drug of choice to be used in the treatment of chronic myeloid leukaemia is Myleran. Total clinical and haematologic remissions are generally, obtained.Other antimitotic agents are efficient, especially in Myleran resistant cases. Radioactive isotopes, such as P32 and A1*" can also be used.Due to more protean aspect of the disease, the treatment of lymphoid leukemia is more difficult. The best drug in such a case is chlorambucil, which can be associated with Röntgen therapy in cases with large lymphadenopathies, or with corticoid hormones in cases with anaemia.Other chemotherapeutic agents have been tested, such as Fe3', Dopan, Sarcolysine, Degranol and Endoxan, but none of them seem better than Myleran and Leukeran.

 

点击下载:  PDF (4599KB)



返 回